Richard M. Glickman

Filings by Richard M. Glickman span 2 companies, the busiest being enGene Holdings Inc. and ESSA Pharma Inc. The record holds 4 filings, for trades running from 31 October 2023 to 9 October 2025.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 15 October 2025 came the latest disclosure, a transaction in ESSA Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.